Tumor Micro Environments in Breast Cancer: Metabolic Regulation, Immunotherapeutic Delivery disease Management
Breast Cancer: Classification and Conventional Management Breast cancer (BC) is defined as a complex disease characterized
Scientific Notes
The evolution of alternatives to animal testing: A 3R timeline
For over a century, animal experimentation has served as the bedrock of biomedical research and toxicology.
A new era in preclinical testing: The 3D model for breast cancer immunotherapies
In oncological research, the development of a 3D model for breast cancer immunotherapies marks a pivotal
New approaches methodologies for hormone receptor-positive (Luminal A/B) breast cancer
Luminal A and B breast cancers, collectively known as hormone receptor–positive (HR+) disease, represent the most
SVF vs ADSC for 3D adipose culture: What source to use?
In this discussion, we investigate the optimal cell source for constructing 3D adipose models, predicated on
Applications of HER2+ organoids and NAMs to study breast cancer
HER2-positive breast cancer represents about one quarter of breast malignancies and is driven by amplification of
Triple-Negative Breast Cancer and the Application of Breast Cancer Organoid Models
Triple-negative breast cancer (TNBC) is a distinct pathological subtype defined by the absence of estrogen receptor
10 Groundbreaking Studies Using 3D Adipose Tissue Models (2020-2025)
Obesity and its related metabolic diseases, such as type 2 diabetes, represent a growing global health
From 2D to 3D: Restoring in vitro liver models functions
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
In vitro liver models in drug discovery: Main models, advantages and use cases
In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!